Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.80 |
| ▸ | CA4 | P22748 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | FYN | P06241 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27931201 | 1.00 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL597260 | 1.00 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL8098477 | 1.00 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL21848043 | 1.00 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL4807077 | 1.00 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL16268261 | 0.95 | CA1 (0.82) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL1541386 | 0.95 | CA1 (0.73) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL19671 | 0.95 | CA1 (0.89) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL25312642 | 0.90 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 | |
| Acetic Acid SCHEMBL25170206 | 0.90 | CA1 (0.80) | CA1CA4LMNATSHRFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113786741-B | Preparation method of coordination polymer composite membrane | 西湖大学 | 2023-02-14 | — | — | CN | claimed |
| CN-113786741-A | Preparation method of coordination polymer composite membrane | 西湖大学 | 2021-12-14 | — | — | CN | claimed |
| US-20170077403-A1 | METHOD FOR FABRICATING LARGE METAL NANOFIBER ELECTRODE ARRAY USING ALIGNED METAL NANOFIBER | POSTECH ACADEMY- INDUSTRY FOUNDATION (KR) | 2017-03-16 | — | — | US | claimed |
| WO-2014119943-A1 | METHOD FOR FABRICATING LARGE METAL NANOFIBER ELECTRODE ARRAY USING ALIGNED METAL NANOFIBER | 포항공과대학교 산학협력단 (KR) | 2014-08-07 | — | — | WO | claimed |
| CN-1795964-A | Heat Recovery System for Renewable Absorbent Materials | YAGAOSI ADVANCED TECH CO LTD (HK) | 2006-07-05 | — | — | CN | claimed |
| US-20260091049-A1 | HALIDE-FREE AMMONIUM SILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2026-04-02 | — | — | US | disclosed |
| US-20250346910-A1 | METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION | COMMENSE BIO INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250304604-A1 | ORGANOSILANES FOR THE TREATMENT OF INFECTIONS | TOPIKOS SCIENTIFIC, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250304605-A1 | ANTIMICROBIAL ORGANOSILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2025-10-02 | — | — | US | disclosed |
| EP-4243901-B1 | PLUG FOR INSERTION INTO THE NOSE OR EAR OF A SUBJECT FOR ADMINISTERING A FLUID THERAPEUTIC AGENT | HOGNE AB (SE) | 2025-06-18 | — | — | EP | disclosed |
| US-20250127802-A1 | HALIDE-FREE AMMONIUM SILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2025-04-24 | — | — | US | disclosed |
| US-12264170-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| CN-1273215-C | Catalyst for producing carboxylic acid ester and process for producing carboxylic acid ester | NIPPON CATALYTIC CHEM IND (JP) | 2006-09-06 | — | — | CN | disclosed |
| CN-1827212-A | Catalyst for carboxylic ester production and process for producing carboxylic ester | NIPPON CATALYTIC CHEM IND (JP) | 2006-09-06 | — | — | CN | disclosed |
| CN-1795964-A | Heat Recovery System for Renewable Absorbent Materials | YAGAOSI ADVANCED TECH CO LTD (HK) | 2006-07-05 | — | — | CN | disclosed |
| US-6962628-B1 | Method of treating epoxy resin-cured product | HITACHI CHEMICAL CO., LTD. (JP) | 2005-11-08 | — | — | US | disclosed |
| CN-1185286-C | Method of treating epoxy resin-cured product | HITACHI CHEMICAL CO LTD (JP) | 2005-01-19 | — | — | CN | disclosed |
| CN-1516619-A | Catalyst for producing carboxylic acid ester and process for producing carboxylic acid ester | ��ʽ�����ձ���ý | 2004-07-28 | — | — | CN | disclosed |
| CN-1434838-A | Method of treating epoxy resin-cured product | HITACHI CHEMICAL CO LTD (JP) | 2003-08-06 | — | — | CN | disclosed |
| US-5939219-A | High-temperature fuel cell having at least one electrically insulating covering and method for producing a high-temperature fuel cell | SIEMENS AKTIENGESELLSCHAFT (DE) | 1999-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304605-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | CA1 4028/4885CA4 2343/4885LMNA 4596/4885 |
| US-20260091049-A1 | HALIDE-FREE AMMONIUM SILANES | TAS1R3, CLCN2, TAS1R1 | CA1 2492/4885CA4 1378/4885LMNA 2469/4885 |
| US-12264170-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | CA1 4028/4885CA4 2343/4885LMNA 4596/4885 |
| US-20250127802-A1 | HALIDE-FREE AMMONIUM SILANES | AAAS, ASPH, ASNS | CA1 2541/4885CA4 2142/4885LMNA 1313/4885 |
| US-20250304604-A1 | ORGANOSILANES FOR THE TREATMENT OF INFECTIONS | ASNS, ACMSD, ARG1 | CA1 2079/4885CA4 444/4885LMNA 4264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.